CN1255044A - 苦瓜中的口服活性成分,其活性肽,及它们治疗糖尿病的用途 - Google Patents

苦瓜中的口服活性成分,其活性肽,及它们治疗糖尿病的用途 Download PDF

Info

Publication number
CN1255044A
CN1255044A CN98805001A CN98805001A CN1255044A CN 1255044 A CN1255044 A CN 1255044A CN 98805001 A CN98805001 A CN 98805001A CN 98805001 A CN98805001 A CN 98805001A CN 1255044 A CN1255044 A CN 1255044A
Authority
CN
China
Prior art keywords
diabetes
type
orally
pharmaceutical composition
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98805001A
Other languages
English (en)
Chinese (zh)
Inventor
B·纳格
S·麦迪彻拉
S·D·沙玛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calyx Therapeutics Inc
Original Assignee
Calyx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calyx Therapeutics Inc filed Critical Calyx Therapeutics Inc
Publication of CN1255044A publication Critical patent/CN1255044A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN98805001A 1997-04-01 1998-04-01 苦瓜中的口服活性成分,其活性肽,及它们治疗糖尿病的用途 Pending CN1255044A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US83103997A 1997-04-01 1997-04-01
US08/831,039 1997-04-01
US85085597A 1997-05-02 1997-05-02
US08/850,855 1997-05-02

Publications (1)

Publication Number Publication Date
CN1255044A true CN1255044A (zh) 2000-05-31

Family

ID=27125412

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98805001A Pending CN1255044A (zh) 1997-04-01 1998-04-01 苦瓜中的口服活性成分,其活性肽,及它们治疗糖尿病的用途

Country Status (11)

Country Link
US (3) US6127338A (enExample)
EP (1) EP1005274B1 (enExample)
JP (1) JP4156038B2 (enExample)
KR (1) KR100509438B1 (enExample)
CN (1) CN1255044A (enExample)
AT (1) ATE403672T1 (enExample)
AU (1) AU749792B2 (enExample)
CA (1) CA2285452A1 (enExample)
DE (1) DE69839842D1 (enExample)
ES (1) ES2310006T3 (enExample)
WO (1) WO1998043484A1 (enExample)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101824073A (zh) * 2010-05-20 2010-09-08 中国药科大学 微波促进固相合成苦瓜mc-jj0103多肽类似物及其应用
CN101824075A (zh) * 2010-05-20 2010-09-08 中国药科大学 微波促进固相合成苦瓜mc-jj0101多肽类似物及其应用
CN101824076A (zh) * 2010-05-20 2010-09-08 中国药科大学 微波促进固相合成苦瓜mc-jj0105多肽类似物及其应用
CN101824074A (zh) * 2010-05-20 2010-09-08 中国药科大学 微波促进固相合成苦瓜mc-jj0107多肽类似物及其应用
CN101830969A (zh) * 2010-05-20 2010-09-15 中国药科大学 微波促进固相合成苦瓜降血糖mc-jj0104多肽类似物及其应用
CN101838309A (zh) * 2010-05-20 2010-09-22 中国药科大学 微波促进固相合成苦瓜mc-jj0102多肽类似物及其应用
CN101942010A (zh) * 2010-05-20 2011-01-12 中国药科大学 微波促进固相合成苦瓜mc-jj0106多肽类似物及其应用
WO2011032359A1 (zh) * 2009-09-17 2011-03-24 中国药科大学 苦瓜mc-jj6多肽及其应用与微波促进固相合成方法
WO2011032360A1 (zh) * 2009-09-17 2011-03-24 中国药科大学 苦瓜mc-jj2多肽及其应用与微波促进固相合成方法
CN101691394B (zh) * 2009-09-17 2012-05-09 中国药科大学 微波促进固相合成苦瓜mc-jj6多肽类似物及其应用
CN103421086A (zh) * 2012-05-18 2013-12-04 中国医药大学 多胜肽、编码该多胜肽的核酸分子、以及该多胜肽的应用
CN104650198A (zh) * 2015-02-09 2015-05-27 马海龙 三叉黑顶藻中分离的能治疗糖尿病的活性肽及其用途
CN106729606A (zh) * 2017-01-03 2017-05-31 河北省农林科学院经济作物研究所 苦瓜降糖提取物复合剂及其制备方法
CN107412721A (zh) * 2017-09-15 2017-12-01 李玉保 一种降血糖苦瓜多肽复方胶囊及其制备方法
CN112675292A (zh) * 2021-01-11 2021-04-20 北京欣颂生物科技有限公司 含有益生菌的制剂在治疗疾病中的应用
CN116813700A (zh) * 2022-11-08 2023-09-29 苏秀兰 一种苦瓜生物活性肽、制备方法及其应用
CN117700489A (zh) * 2023-12-19 2024-03-15 深圳泰华赛尔生物科技有限公司 脂肪干细胞在治疗糖尿病的药物中的应用

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1171455B1 (en) * 1999-04-13 2008-11-19 Pushpa Khanna Polypeptide-k obtained from momordica charantia and a process for the extraction thereof
WO2005063156A1 (en) * 2003-12-22 2005-07-14 Shear/Kershman Laboratories, Inc. Oral peptide delivery system with improved bioavailability
EP1563842A1 (en) * 2004-02-03 2005-08-17 Novartis AG Simarouba amara and/or Momordica charantia extracts for the treatment of coccidiosis in poultry
US20070269898A1 (en) * 2004-09-15 2007-11-22 Yokohama City University Amino Acid Sequences Essential to Neuron Specific Gene Expression
WO2008120240A1 (en) * 2007-03-30 2008-10-09 Aparna Dixit Anti diabetic protein
US20100081860A1 (en) * 2008-04-24 2010-04-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational System and Method for Memory Modification
TWI342781B (en) * 2008-12-01 2011-06-01 Univ China Medical Blood sugar-modulating polypeptides
CN101985644B (zh) * 2010-10-25 2013-06-12 邹远东 一种苦瓜多肽及其制备方法与应用
ES2621355T3 (es) 2011-01-28 2017-07-03 Piramal Enterprises Limited Procedimiento para la preparación de un extracto de Momordica Charantia
CN107412720A (zh) * 2017-09-15 2017-12-01 李玉保 一种治疗糖尿病的苦瓜多肽复方植物药及其制备方法
CN108707181B (zh) * 2018-06-14 2021-03-12 苏秀兰 一种抑制肿瘤细胞增殖的苦瓜多肽及其制备方法和应用
CN110755598A (zh) * 2019-10-25 2020-02-07 李玉保 活化胰岛素及治疗糖尿病的复合苦瓜肽口服药及制备方法
CN119320429B (zh) * 2024-10-15 2025-07-29 天津桂芝堂科技有限公司 包含乳铁蛋白的药物组合物及在降血脂中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3853914A (en) * 1971-01-11 1974-12-10 Syva Co Ligand determination of spin labeled compounds by receptor displacement
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3905654A (en) * 1973-11-14 1975-09-16 Kelsey Hayes Co Skid control system for dual brake
US3945988A (en) * 1974-07-16 1976-03-23 Pushpa Khann Process for isolation of insulin from plant source
US4043989A (en) * 1975-09-11 1977-08-23 Syva Company Oxazepam derivatives for immunoassay reagents
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
US4156081A (en) * 1977-04-15 1979-05-22 Syva Company Theophylline antigens and antibodies
JPS57106626A (en) * 1980-12-22 1982-07-02 Teijin Ltd Cytotoxic protein complex and its preparation
US5098710A (en) * 1987-06-18 1992-03-24 Yaguang Liu Production of kuguasu
US5086043A (en) * 1987-06-18 1992-02-04 Yaguang Liu Production of Saponins of Lichi
US4985248A (en) * 1987-06-18 1991-01-15 Yaguang Liu Pharmaceutical composition containing a safe extracts of fruits and vegetables for the treating and preventing of diabetes
ES2128362T3 (es) * 1991-12-03 1999-05-16 Proteus Molecular Design Fragmentos de proteinas de prion.
US5750361A (en) * 1995-11-02 1998-05-12 The Regents Of The University Of California Formation and use of prion protein (PRP) complexes

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011032359A1 (zh) * 2009-09-17 2011-03-24 中国药科大学 苦瓜mc-jj6多肽及其应用与微波促进固相合成方法
CN101691394B (zh) * 2009-09-17 2012-05-09 中国药科大学 微波促进固相合成苦瓜mc-jj6多肽类似物及其应用
WO2011032360A1 (zh) * 2009-09-17 2011-03-24 中国药科大学 苦瓜mc-jj2多肽及其应用与微波促进固相合成方法
CN101830969A (zh) * 2010-05-20 2010-09-15 中国药科大学 微波促进固相合成苦瓜降血糖mc-jj0104多肽类似物及其应用
CN101824073A (zh) * 2010-05-20 2010-09-08 中国药科大学 微波促进固相合成苦瓜mc-jj0103多肽类似物及其应用
CN101838309A (zh) * 2010-05-20 2010-09-22 中国药科大学 微波促进固相合成苦瓜mc-jj0102多肽类似物及其应用
CN101942010A (zh) * 2010-05-20 2011-01-12 中国药科大学 微波促进固相合成苦瓜mc-jj0106多肽类似物及其应用
CN101824074A (zh) * 2010-05-20 2010-09-08 中国药科大学 微波促进固相合成苦瓜mc-jj0107多肽类似物及其应用
CN101824076A (zh) * 2010-05-20 2010-09-08 中国药科大学 微波促进固相合成苦瓜mc-jj0105多肽类似物及其应用
CN101824075A (zh) * 2010-05-20 2010-09-08 中国药科大学 微波促进固相合成苦瓜mc-jj0101多肽类似物及其应用
CN103421086A (zh) * 2012-05-18 2013-12-04 中国医药大学 多胜肽、编码该多胜肽的核酸分子、以及该多胜肽的应用
CN104650198A (zh) * 2015-02-09 2015-05-27 马海龙 三叉黑顶藻中分离的能治疗糖尿病的活性肽及其用途
CN106729606A (zh) * 2017-01-03 2017-05-31 河北省农林科学院经济作物研究所 苦瓜降糖提取物复合剂及其制备方法
CN107412721A (zh) * 2017-09-15 2017-12-01 李玉保 一种降血糖苦瓜多肽复方胶囊及其制备方法
CN112675292A (zh) * 2021-01-11 2021-04-20 北京欣颂生物科技有限公司 含有益生菌的制剂在治疗疾病中的应用
CN112675292B (zh) * 2021-01-11 2021-11-02 中食安泓(广东)健康产业有限公司 含有益生菌的制剂在治疗疾病中的应用
CN116813700A (zh) * 2022-11-08 2023-09-29 苏秀兰 一种苦瓜生物活性肽、制备方法及其应用
CN117700489A (zh) * 2023-12-19 2024-03-15 深圳泰华赛尔生物科技有限公司 脂肪干细胞在治疗糖尿病的药物中的应用

Also Published As

Publication number Publication date
EP1005274B1 (en) 2008-08-06
US6852695B2 (en) 2005-02-08
DE69839842D1 (de) 2008-09-18
ES2310006T3 (es) 2008-12-16
CA2285452A1 (en) 1998-10-08
AU749792B2 (en) 2002-07-04
US6127338A (en) 2000-10-03
US6391854B1 (en) 2002-05-21
EP1005274A4 (en) 2004-09-08
WO1998043484A1 (en) 1998-10-08
JP2002516608A (ja) 2002-06-04
AU6876598A (en) 1998-10-22
JP4156038B2 (ja) 2008-09-24
EP1005274A1 (en) 2000-06-07
US20020193310A1 (en) 2002-12-19
KR20010005917A (ko) 2001-01-15
KR100509438B1 (ko) 2005-08-23
ATE403672T1 (de) 2008-08-15

Similar Documents

Publication Publication Date Title
CN1255044A (zh) 苦瓜中的口服活性成分,其活性肽,及它们治疗糖尿病的用途
AU2004202293B2 (en) Methods for Glucagon Suppression
JP6895883B2 (ja) オキシントモジュリン類似体、薬物組成物、糖尿病治療薬、血糖降下薬及び体重低下薬
JP4044140B2 (ja) インスリン誘導体類とその使用
CN103189389B (zh) 新的glp‑ⅰ类似物及其制备方法和用途
ZA200306332B (en) Methods of treating diabetes mellitus
AU2002244020A1 (en) Methods of treating diabetes mellitus
CN118598978A (zh) 胰岛素衍生物
ZA200406332B (en) ACC inhibitors.
EP2029160A2 (en) Methods to restore glycemic control
EP4317179A1 (en) Gip and glp-1 dual receptor agonist, pharmaceutical composition, and use
WO2023000240A1 (zh) 长效glp-1多肽类似物及其制备方法和应用
WO2005072045A2 (en) The combined use of glp-1 agonists and gastrin for regulating blood glucose levels
EP3653639B1 (en) Polypeptide and composition thereof for treating diseases of metabolic system
HK1027008A (en) Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes
CN115073582B (zh) 多肽化合物及其在预防或治疗糖尿病或糖尿病并发症中的应用
WO2017152861A1 (en) Conjugates of islet neogenesis peptides and analogs, and methods thereof
WO2025228255A1 (zh) 酰化人胰岛素类似物
KR20170069997A (ko) 미리스토일화된 렙틴-관련된 펩티드 및 이들의 용도
CA2638968A1 (en) Vasoactive intestinal polypeptide pharmaceuticals

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1027008

Country of ref document: HK